BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11972310)

  • 1. Megestrol acetate to correct the nutritional status in an adolescent with growth hormone deficiency: Increase of appetite and body weight but only by increase of body water and fat mass followed by profound cortisol and testosterone depletion.
    Schmid I; Stachel DK; Freudenberg S; Schmitt M; Schuster F; Haas RJ
    Klin Padiatr; 2002; 214(2):54-7. PubMed ID: 11972310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life and stimulation of weight gain after treatment with megestrol acetate: correlation between cytokine levels and nutritional status, appetite in geriatric patients with wasting syndrome.
    Yeh S; Wu SY; Levine DM; Parker TS; Olson JS; Stevens MR; Schuster MW
    J Nutr Health Aging; 2000; 4(4):246-51. PubMed ID: 11115810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Megestrol acetate in pediatric oncology patients may lead to severe, symptomatic adrenal suppression.
    Orme LM; Bond JD; Humphrey MS; Zacharin MR; Downie PA; Jamsen KM; Mitchell SL; Robinson JM; Grapsas NA; Ashley DM
    Cancer; 2003 Jul; 98(2):397-405. PubMed ID: 12872362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Low doses of megestrol acetate increase weight and improve nutrition status in patients with severe chronic obstructive pulmonary disease and weight loss].
    Herrejón A; Palop J; Inchaurraga I; López A; Bañuls C; Hernández A; Blanquer R; Están N; Anguera A
    Med Clin (Barc); 2011 Jul; 137(5):193-8. PubMed ID: 21524765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone supplementation of megestrol therapy does not enhance lean tissue accrual in men with human immunodeficiency virus-associated weight loss: a randomized, double-blind, placebo-controlled, multicenter trial.
    Mulligan K; Zackin R; Von Roenn JH; Chesney MA; Egorin MJ; Sattler FR; Benson CA; Liu T; Umbleja T; Shriver S; Auchus RJ; Schambelan M;
    J Clin Endocrinol Metab; 2007 Feb; 92(2):563-70. PubMed ID: 17090640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, double-blind, placebo-controlled clinical trial of megestrol acetate as an appetite stimulant in children with weight loss due to cancer and/or cancer therapy.
    Cuvelier GD; Baker TJ; Peddie EF; Casey LM; Lambert PJ; Distefano DS; Wardle MG; Mychajlunow BA; Romanick MA; Dix DB; Wilson BA
    Pediatr Blood Cancer; 2014 Apr; 61(4):672-9. PubMed ID: 24167059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anorexia/cachexia in patients with HIV: lessons for the oncologist.
    Von Roenn JH; Knopf K
    Oncology (Williston Park); 1996 Jul; 10(7):1049-56; discussion 1062-4, 1067-8. PubMed ID: 8837121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of megestrol acetate on weight gain, body composition, and pulmonary function in patients with cystic fibrosis.
    Eubanks V; Koppersmith N; Wooldridge N; Clancy JP; Lyrene R; Arani RB; Lee J; Moldawer L; Atchison J; Sorscher EJ; Makris CM
    J Pediatr; 2002 Apr; 140(4):439-44. PubMed ID: 12006958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of megestrol acetate and testosterone on body composition in castrated male Sprague-Dawley rats.
    Engelson ES; PI-Sunyer FX; Kotler DP
    Nutrition; 1999 Jun; 15(6):465-73. PubMed ID: 10378202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palliative treatment of cancer anorexia with oral suspension of megestrol acetate.
    Tomíska M; Tomisková M; Salajka F; Adam Z; Vorlícek J
    Neoplasma; 2003; 50(3):227-33. PubMed ID: 12937858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
    Robaczyk MG
    Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort.
    Jatoi A; Rowland K; Loprinzi CL; Sloan JA; Dakhil SR; MacDonald N; Gagnon B; Novotny PJ; Mailliard JA; Bushey TI; Nair S; Christensen B;
    J Clin Oncol; 2004 Jun; 22(12):2469-76. PubMed ID: 15197210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, double-blind, placebo-controlled pilot trial of megestrol acetate in malnourished children with cystic fibrosis.
    Marchand V; Baker SS; Stark TJ; Baker RD
    J Pediatr Gastroenterol Nutr; 2000 Sep; 31(3):264-9. PubMed ID: 10997370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer.
    Bruera E; Macmillan K; Kuehn N; Hanson J; MacDonald RN
    Cancer; 1990 Sep; 66(6):1279-82. PubMed ID: 2205358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement in quality-of-life measures and stimulation of weight gain after treatment with megestrol acetate oral suspension in geriatric cachexia: results of a double-blind, placebo-controlled study.
    Yeh SS; Wu SY; Lee TP; Olson JS; Stevens MR; Dixon T; Porcelli RJ; Schuster MW
    J Am Geriatr Soc; 2000 May; 48(5):485-92. PubMed ID: 10811540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The influence of long-term growth hormone replacement therapy on body composition, bone tissue and some metabolic parameters in adults with growth hormone deficiency].
    Olsovská V; Siprová H; Beránek M; Soska V
    Vnitr Lek; 2005 Dec; 51(12):1356-64. PubMed ID: 16430102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors relating blood markers of inflammation and nutritional status to survival in cachectic geriatric patients in a randomized clinical trial.
    Yeh SS; Hafner A; Chang CK; Levine DM; Parker TS; Schuster MW
    J Am Geriatr Soc; 2004 Oct; 52(10):1708-12. PubMed ID: 15450049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W; Briody J; Moore B; Lu PW; Cowell CT
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective study of the association between megestrol acetate administration and mortality among nursing home residents with clinically significant weight loss.
    Bodenner D; Spencer T; Riggs AT; Redman C; Strunk B; Hughes T
    Am J Geriatr Pharmacother; 2007 Jun; 5(2):137-46. PubMed ID: 17719516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of anorexia and malnutrition in peritoneal dialysis patients with megestrol acetate.
    Costero O; Bajo MA; del Peso G; Gil F; Aguilera A; Ros S; Hevia C; Selgas R
    Adv Perit Dial; 2004; 20():209-12. PubMed ID: 15384828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.